We report a case of neonatal withdrawal syndrome after in utero exposure to paroxetine 20 mg/day. The infant’s symptoms, such as poor neonatal adaptation, respiratory distress, decerebrate posturing, irritability and tremors, commenced soon after birth and persisted for 5 days. All neonates exposed to antidepressants, particularly serotonin reuptake inhibitors (SSRIs), during the last trimester should be followed-up closely for adverse symptoms.
Paroxetine and neonatal withdrawal syndrome / L. Pogliani, L. Schneider, D. Dilillo, F. Penagini, G.V. Zuccotti. - In: BMJ CASE REPORT. - ISSN 1757-790X. - (2010 Apr 29). [10.1136/bcr.12.2009.2528]
Paroxetine and neonatal withdrawal syndrome
L. SchneiderSecondo
;F. PenaginiPenultimo
;G.V. ZuccottiUltimo
2010
Abstract
We report a case of neonatal withdrawal syndrome after in utero exposure to paroxetine 20 mg/day. The infant’s symptoms, such as poor neonatal adaptation, respiratory distress, decerebrate posturing, irritability and tremors, commenced soon after birth and persisted for 5 days. All neonates exposed to antidepressants, particularly serotonin reuptake inhibitors (SSRIs), during the last trimester should be followed-up closely for adverse symptoms.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
